Back to trial detailsIntake questionnaire
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Applying to Florida Cancer Specialists & Research Institute - South · Fort Myers, Florida
Answer a few short questions to share with the research team.
0 of 4 answered